- Nurx, a Silicon Valley prescription drug delivery startup that once solely dispensed birth control, is launching a new service that allows patients who want HIV-prevention drug Truvada to do the required testing at home.
- It’s a big move for the company, which recently raised $ 36 million and added Chelsea Clinton to its board of advisers.
- It’s also a big deal for people seeking HIV-prevention drugs, who currently battle stigma and potentially wait months to get the medication.
In a move that could hint at bigger plans for prescription drug delivery, Silicon Valley startup Nurx on Wednesday launched the first at-home test of its kind for HIV-prevention drug Truvada.
Getting the daily pill, which is estimated to reduce infection among high-risk people by more than 90%, is no easy task. It can take several months for someone who wants PrEP to actually receive the drug. Nurx’s new service is designed to shrink that waiting period to just a few days.See the rest of the story at Business Insider
- US investors are pouring millions into a healthcare company that doesn’t take insurance and lists its prices like a ‘McDonald’s menu’
- We spoke with the woman shaking up GM’s health plans, and what she said should terrify health insurers
- The first app to get approved as birth control in Europe has now been green-lit in the US, despite controversy